Company Overview and News

Carlsberg Q1 earnings rise to RM81mil

Strong growth: Lehmann says Carlsberg is proud to deliver strong growth in both revenue and net profit.

Consumer stocks seen shielded from trade war

CONSUMER stocks would be a good industry to hide in should a global trade war break out.

Pushing the business and political nexus too far is bad

Richest man: Based on listed companies, Kuok is the richest man in Malaysia, worth almost RM50bil as at the end of last year.

MNCs losing their lustre

LISTED multinational companies (MNCs) on the Malaysian market have long been the darling of investors for two major reasons – low-risk nature and decent dividend yields.

Breakfast briefing: Friday, August 18

MarketWatch: US stocks sold off on Thursday, with the S&P 500 recording its biggest daily percentage drop in three months as escalating worries about the Trump administration's ability to push through its economic agenda rattled investors. The DJIA ended down 274.14 points, or 1.24%, to 21,750.73, the S&P 500 lost 38.1 points, or 1.54%, to 2,430.01 and the Nasdaq dropped 123.20 points, or 1.94%, to 6,221.

KLCI remains in negative zone, in line with region

2017-04-10 theedgemarkets
KUALA LUMPUR (April 10): The FBM KLCI remained in negative zone at the midday break today, in line with most regional markets.

KLCI falls 0.28%, slips to below 1,740 level

2017-04-06 theedgemarkets
KUALA LUMPUR (April 6): The FBM KLCI fell 0.28% and slipped to below the 1,740-point level at the midday break today, in line with the lacklustre regional markets.

KLCI jumps 0.85%, key blue chips lift

2017-03-02 theedgemarkets
KUALA LUMPUR (March 2): The FBM KLCI jumped 0.85% at the midday break today, lifted by key blue chips, in line with the gains at most regional markets.

KLCI pares gains as sentiment stays nervy

2017-02-22 theedgemarkets
KUALA LUMPUR (Feb 22): The FBM KLCI pared some of its gains at mid-morning today, as local sentiment stayed nervy.

Breakfast briefing: Wednesday, February 22

MarketWrap: US stocks rose to fresh record highs on Tuesday, boosted by strong earnings reports from Wal-Mart and Home Depot and continued optimism about the economic agenda of President Donald Trump. - Reuters The DJIA rose 118.95 points, or 0.58%, to 20,743, the S&P 500 gained 14.22 points, or 0.60%, to 2,365.38 and the Nasdaq added 27.37 points, or 0.47%, to 5,865.95. Energy Oil prices ended about 1% higher after touching three-week highs on Tuesday on Opec's optimism for greater compliance with its deal with other producers including Russia to curb output in an effort to clear a glut that has weighed on the market.

KLCI to cautiously defend 1,700-level

2017-02-21 theedgemarkets
KUALA LUMPUR (Feb 22): The FBM KLCI is expected to cautiously defend its 1,700-point level today in line with the overnight gains at most global markets.

KPJ Healthcare, Hong Leong Financial Group, Pharmaniaga, Mercury Industries, IOI Properties Group, Parkson Holdings, Carlsberg Brewery Malaysia, Scan Associates, Malaysian Bulk Carriers, Ann Joo Resources, Perdana Petroleum and Serba Dinamik Holdings

2017-02-21 theedgemarkets
KUALA LUMPUR (Feb 21): Based on corporate announcements and news flow today, the companies that may be in focus tomorrow (Feb 22) could be KPJ Healthcare Bhd, Hong Leong Financial Group Bhd (HLFG), Pharmaniaga Bhd, Mercury Industries Bhd, IOI Properties Group Bhd, Malaysian Bulk Carriers Bhd, Parkson Holdings Bhd, Carlsberg Brewery Malaysia Bhd, Scan Associates Bhd, Ann Joo Resources Bhd and Serba Dinamik Holdings Bhd.

KLCI down 0.3% amidst lack of buying catalyst

2017-02-21 theedgemarkets
KUALA LUMPUR (Feb 21): The FBM KLCI dropped 6.03 points or 0.3% to close at 1,706.55 points today. Share prices ended the day mostly lower with 552 decliners outnumbering 364 winners amidst lack of impetus to sustain recent buying interest on Bursa Malaysia.

KLCI reverses gains as sellers outpace buyers

2017-02-21 theedgemarkets
KUALA LUMPUR (Feb 21): The FBM KLCI reversed its gains and fell at the midday break today as sellers outpaced buyers and sentiment turned negative on profit taking.

KLCI pares gains as profit taking sets in

2017-02-21 theedgemarkets
KUALA LUMPUR (Feb 21): The FBM KLCI pared some of its gains at mid-morning today as some mild profit taking sets in at the local market.

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

22h - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

23h - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...